Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FATE | AMGN | BMY | GILD | VRTX |
| Company | Fate Therapeutics | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 3.86 | 314.34 | 44.70 | 64.79 | 419.00 |
| High | 3.86 | 314.34 | 44.70 | 64.79 | 421.18 |
| Low | 3.86 | 314.34 | 44.70 | 64.79 | 416.03 |
| Last | 3.80 | 312.48 | 44.80 | 65.33 | 417.66 |
| Change | -0.10 | -0.38 | +0.06 | +0.75 | -1.33 |
| % Change | -2.56% | -0.12% | +0.13% | +1.16% | -0.32% |
| Volume | 2,402 | 391,581 | 7,340 | 940,166 | 676,100 |
| 20-Day Average Volume | 2,767,375 | 2,819,849 | 13,733,767 | 7,224,723 | 1,114,570 |
| Previous Close | 3.90 | 312.86 | 44.74 | 64.58 | 418.82 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.36 | 281.82 | 46.00 | 65.94 | 400.63 |
| 20-Day Raw Stochastic | 11.79% | 86.66% | 21.95% | 11.15% | 80.77% |
| 20-Day Relative Strength | 33.51% | 68.57% | 35.58% | 33.11% | 60.08% |
| Weighted Alpha | -51.73 | +36.54 | -34.77 | -21.26 | +21.42 |
| Today's Opinion | 24% Sell | 56% Buy | 100% Sell | 100% Sell | 56% Buy |
| Previous Opinion | 24% Sell | 56% Buy | 100% Sell | 100% Sell | 56% Buy |
| Last Month's Opinion | 40% Buy | 40% Sell | 56% Sell | 100% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.93% since 05/03/24 | +0.98% since 05/03/24 | +1.61% since 05/03/24 | +0.02% since 05/03/24 | +4.71% since 05/02/24 |
| Low | 3.58 on 05/08/24 | 297.52 on 05/06/24 | 43.49 on 05/09/24 | 64.34 on 05/06/24 | 394.03 on 05/07/24 |
| High | 4.26 on 05/06/24 | 314.60 on 05/09/24 | 44.81 on 05/09/24 | 66.14 on 05/07/24 | 425.65 on 05/08/24 |
| 1-Month | |||||
| %Chg | -38.44% since 04/10/24 | +17.97% since 04/10/24 | -11.12% since 04/10/24 | -4.89% since 04/10/24 | +3.59% since 04/09/24 |
| Low | 3.58 on 05/08/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 6.37 on 04/11/24 | 322.60 on 05/03/24 | 50.58 on 04/11/24 | 69.03 on 04/11/24 | 425.65 on 05/08/24 |
| 3-Month | |||||
| %Chg | -38.63% since 02/09/24 | +7.98% since 02/09/24 | -10.26% since 02/09/24 | -12.05% since 02/09/24 | -0.93% since 02/09/24 |
| Low | 3.58 on 05/08/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 8.83 on 03/07/24 | 322.60 on 05/03/24 | 55.03 on 03/13/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | +87.38% since 11/10/23 | +17.59% since 11/10/23 | -11.68% since 11/10/23 | -14.66% since 11/10/23 | +13.68% since 11/09/23 |
| Low | 1.94 on 11/13/23 | 260.52 on 11/21/23 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 341.90 on 11/16/23 |
| High | 8.83 on 03/07/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 443,886 | 167,829,040 | 90,692,464 | 80,407,072 | 108,121,632 |
| Shares Outstanding, K | 113,817 | 536,435 | 2,027,100 | 1,245,077 | 258,053 |
| Annual Sales | 63,530,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -160,930,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 1,680,000 | 7,447,000,000 | 11,865,000,000 | 6,686,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -44,120,000 | -113,000,000 | -11,911,000,000 | -4,170,000,000 | 968,800,000 |
| 60-Month Beta | 1.80 | 0.60 | 0.45 | 0.22 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.45 on 02/26/24 | 3.96 on 05/02/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 41.59 | 16.11 | 27.81 |